FDA Inspection 873865 — Sunshine Lake Pharma Co., Ltd

Sunshine Lake Pharma Co., Ltd — FEI 3007721552

The FDA completed an inspection of Sunshine Lake Pharma Co., Ltd on March 14, 2014 in Dongguan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 14, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dongguan (China)